Lin TS - Search Results

1

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.

Alinari L, Lapalombella R, Andritsos L, Baiocchi RA, Lin TS, Byrd JC. Alinari L, et al. Among authors: lin ts. Oncogene. 2007 May 28;26(25):3644-53. doi: 10.1038/sj.onc.1210380. Oncogene. 2007. PMID: 17530018 Review.

2

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia.

Lin TS, Flinn IW, Lucas MS, Porcu P, Sickler J, Moran ME, Lucas DM, Heerema NA, Grever MR, Byrd JC. Lin TS, et al. Leukemia. 2005 Jul;19(7):1207-10. doi: 10.1038/sj.leu.2403782. Leukemia. 2005. PMID: 15858611 Clinical Trial.

3

A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Woyach JA, Lin TS, Lucas MS, Heerema N, Moran ME, Cheney C, Lucas DM, Wei L, Caligiuri MA, Byrd JC. Woyach JA, et al. Among authors: lin ts. Leukemia. 2009 May;23(5):912-8. doi: 10.1038/leu.2008.385. Epub 2009 Feb 19. Leukemia. 2009. PMID: 19225537 Free PMC article. Clinical Trial.

4

Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.

Blum KA, Jung SH, Johnson JL, Lin TS, Hsi ED, Lucas DM, Byrd JC, Cheson BD, Bartlett NL; Cancer and Leukemia Group B. Blum KA, et al. Among authors: lin ts. Ann Oncol. 2010 Nov;21(11):2246-2254. doi: 10.1093/annonc/mdq211. Epub 2010 Apr 27. Ann Oncol. 2010. PMID: 20423913 Free PMC article. Clinical Trial.

5

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.

Guinn D, Ruppert AS, Maddocks K, Jaglowski S, Gordon A, Lin TS, Larson R, Marcucci G, Hertlein E, Woyach J, Johnson AJ, Byrd JC. Guinn D, et al. Among authors: lin ts. Leukemia. 2015 May;29(5):1210-3. doi: 10.1038/leu.2014.344. Epub 2014 Dec 9. Leukemia. 2015. PMID: 25486872 Free PMC article. No abstract available.

6

Ibrutinib provides favourable survival outcomes in patients with comorbidities versus established therapies.

Burger JA, Cramer P, Barr PM, Dilhuydy MS, Mato A, Byrd JC, Chang S, Graef T, Lin T, Tedeschi A. Burger JA, et al. Br J Haematol. 2019 Jul;186(1):175-180. doi: 10.1111/bjh.15784. Epub 2019 Feb 10. Br J Haematol. 2019. PMID: 30739324 Free article. No abstract available.

7

Diffuse alveolar hemorrhage following gemtuzumab ozogamicin.

Lin TS, Penza SL, Avalos BR, Lucarelli MR, Farag SS, Byrd JC, Copelan EA. Lin TS, et al. Bone Marrow Transplant. 2005 Apr;35(8):823-4. doi: 10.1038/sj.bmt.1704886. Bone Marrow Transplant. 2005. PMID: 15735659 No abstract available.

8

Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia.

Osterborg A, Foà R, Bezares RF, Dearden C, Dyer MJ, Geisler C, Lin TS, Montillo M, van Oers MH, Wendtner CM, Rai KR. Osterborg A, et al. Among authors: lin ts. Leukemia. 2009 Nov;23(11):1980-8. doi: 10.1038/leu.2009.146. Epub 2009 Jul 23. Leukemia. 2009. PMID: 19626051 Review.

9

Flavopiridol: where do we stand in chronic lymphocytic leukemia?

Lin TS, Porcu P. Lin TS, et al. Leukemia. 2004 Feb;18(2):243-6. doi: 10.1038/sj.leu.2403237. Leukemia. 2004. PMID: 14671637 No abstract available.

10

Second autologous stem cell transplant for multiply relapsed Hodgkin's disease.

Lin TS, Avalos BR, Penza SL, Marcucci G, Elder PJ, Copelan EA. Lin TS, et al. Bone Marrow Transplant. 2002 May;29(9):763-7. doi: 10.1038/sj.bmt.1703546. Bone Marrow Transplant. 2002. PMID: 12040474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

577 results

Search Page

Filters